• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA (SH) TRIFECTA GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA (SH) TRIFECTA GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TFGT-23A
Device Problems Backflow (1064); Biocompatibility (2886); Material Split, Cut or Torn (4008)
Patient Problems Corneal Pannus (1447); Abscess (1690); Aortic Regurgitation (1716); Endocarditis (1834); Cusp Tear (2656)
Event Date 11/04/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
On (b)(6) 2019, a 23mm trifecta¿ gt valve was implanted in the patient due to tight calcified aortic stenosis.In (b)(6) 2020, the patient experienced a large aortic leak without vegetation which lead to hospital care.On (b)(6) 2020, the valve was explanted from the patient due to endocarditis and was replaced with a 21mm magna ease valve.During the procedure, a large abscess in the wall was noted requiring antibiotic treatment.It was also discovered that the bioprosthesis was perforated.There was an incomplete, but very long tear along the prosthesis' commissure located between the left coronary sinus and non-coronary sinus.There was also a large pannus noted under the bioprosthesis.The surgery was successfully completed with stable hemodynamics and it was reported that the patient is currently stable.
 
Manufacturer Narrative
Additional information for: g3, g6, h2, h6, and h10.The reported event of aortic leak, endocarditis, pannus, prosthesis tear, and valve explant could not be confirmed.A more comprehensive assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA GT VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA (SH)
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS  01897-4050
MDR Report Key11098856
MDR Text Key224518329
Report Number3008452825-2020-00734
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05415067018229
UDI-Public05415067018229
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Replace
Type of Report Initial,Followup
Report Date 03/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/30/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/18/2022
Device Model NumberTFGT-23A
Device Catalogue NumberTFGT-23A
Device Lot Number6767970
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received03/05/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age58 YR
-
-